In this Healthed lectue, cardiologist, Professor Andrew Sindone and endocrinologist, Dr Ted Wu discuss the importance of SGLT2 inhibitors for patients with type 2 diabetes and cardiovascular disease, and the ground-breaking evidence that has seen this class of drugs now be recommended as second-line T2D treatment after metformin, particularly for its cardiovascular benefits. Importantly, the experts will also explain recent PBS changes that have improved access to SGLT2 inhibitors as well as other practical considerations associated with these medications.

<p>In this Healthed lectue, cardiologist, Professor Andrew Sindone and endocrinologist, Dr Ted Wu discuss the importance of SGLT2 inhibitors for patients with type 2 diabetes and cardiovascular disease, and the ground-breaking evidence that has seen this class of drugs now be recommended as second-line T2D treatment after metformin, particularly for its cardiovascular benefits. Importantly, the experts will also explain recent PBS changes that have improved access to SGLT2 inhibitors as well as other practical considerations associated with these medications.<br><br></p>

Healthed's medical education channel features the latest high quality clinical interviews and lectures from leading experts in their field, offering health professionals a convenient new way to boost their knowledge.

Advertisement